In a study from Stagg et al., it was shown that CD73−/− Tregs are less tumor-supportive than the WT counterpart (76), indicating a role for CD73 and suggesting that its expression is possibly modulated and induced upon Tregs activation. This evidence concerns the gene NT5E and neoplasm.